540501-04-0 Usage
General Description
2-Amino-4-chloro-5-iodo-benzoic acid is a chemical compound with the molecular formula C7H5ClINO2. It is a derivative of benzoic acid, containing both amino, chloro, and iodo functional groups. 2-AMino-4-chloro-5-iodo-benzoic acid is commonly used in the pharmaceutical industry for the synthesis of various drugs and is also a valuable intermediate in organic synthesis. Its unique combination of substituents makes it a versatile building block for the production of a wide range of pharmaceuticals and other chemical compounds. Additionally, the presence of both amino and halogen groups in its structure makes 2-amino-4-chloro-5-iodo-benzoic acid a valuable tool for studying and manipulating biological systems and chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 540501-04-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,4,0,5,0 and 1 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 540501-04:
(8*5)+(7*4)+(6*0)+(5*5)+(4*0)+(3*1)+(2*0)+(1*4)=100
100 % 10 = 0
So 540501-04-0 is a valid CAS Registry Number.
540501-04-0Relevant articles and documents
QUINAZOLINE DERIVATIVES USEFUL AS SELECTIVE HDAC6 INHIBITORS
-
Paragraph 000188, (2021/12/31)
Provided herein is a compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compo
BENZIMIDAZOLE QUINOLINONES AND USES THEREOF
-
Page 266, (2008/06/13)
Methods of inhibiting various enzymes and treating various conditions are provided that include administering to a subject a compound of Structure I or IB, a pharmaceutically acceptable salt thereof, a tautomer thereof, or a pharmaceutically acceptable salt of the tautomer. Compounds having the Structure I and IB have the following structures and have the variables described herein. Such compounds may be used to prepare medicaments for use in inhibiting various enzymes and for use in treating conditions mediated by such enzymes.
